Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series Study
Bipolar disorder is a chronic and remitting mental illness. Antidepressants are not effective in treating acute bipolar depression, and antipsychotic drugs used in the treatment of bipolar depression cause frequent side effects. This situation justifies the search for new drugs as well as the repurp...
Principais autores: | Marek Krzystanek, Artur Pałasz |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
MDPI AG
2020-10-01
|
coleção: | Pharmaceuticals |
Assuntos: | |
Acesso em linha: | https://www.mdpi.com/1424-8247/13/10/326 |
Registros relacionados
-
Amantadine in Treatment of Dysthymia—The Pilot Case Series Study
por: Marek Krzystanek, et al.
Publicado em: (2023-06-01) -
Possible Antidepressant Effects of Memantine—Systematic Review with a Case Study
por: Marek Krzystanek, et al.
Publicado em: (2021-05-01) -
Differences between Depression Episodes of Bipolar Disorder I and II
por: Leman Inanc, et al.
Publicado em: (2013-09-01) -
Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study
por: Marek Krzystanek, et al.
Publicado em: (2021-09-01) -
Adapted Behavioural Activation for Bipolar Depression: A Randomised Multiple Baseline Case Series
por: Kim Wright, et al.
Publicado em: (2022-10-01)